6.46
price down icon4.01%   -0.27
after-market 시간 외 거래: 6.47 0.010 +0.15%
loading

Aptevo Therapeutics Inc 주식(APVO)의 최신 뉴스

pulisher
Mar 03, 2026

10 Health Care Stocks Moving In Monday's Pre-Market Session - Sahm

Mar 03, 2026
pulisher
Mar 02, 2026

APVO Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Mar 02, 2026
pulisher
Feb 28, 2026

Aptevo Therapeutics (NASDAQ:APVO) Upgraded at Wall Street Zen - Defense World

Feb 28, 2026
pulisher
Feb 25, 2026

Retail Surge: Can Moodys Corporation reach resistance levels soon2025 Momentum Check & Safe Entry Point Identification - baoquankhu1.vn

Feb 25, 2026
pulisher
Feb 25, 2026

APVO SEC FilingsAptevo Therapeutics Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Feb 25, 2026
pulisher
Feb 20, 2026

Aptevo Therapeutics Inc expected to post a loss of $8.10 a shareEarnings Preview - TradingView

Feb 20, 2026
pulisher
Feb 19, 2026

Aptevo Therapeutics Shareholders Approve Expanded Equity Financing Capacity - TipRanks

Feb 19, 2026
pulisher
Feb 17, 2026

12 Health Care Stocks Moving In Tuesday's After-Market Session - Benzinga

Feb 17, 2026
pulisher
Feb 17, 2026

Institution Moves: How volatile is FATBW stockJuly 2025 Drop Watch & Expert Curated Trade Ideas - baoquankhu1.vn

Feb 17, 2026
pulisher
Feb 17, 2026

Aptevo Therapeutics (APVO) sees Point72 report 0% ownership - Stock Titan

Feb 17, 2026
pulisher
Feb 16, 2026

Seattle biotech CEO to step down, replacement named - The Business Journals

Feb 16, 2026
pulisher
Feb 16, 2026

Why Cheetah Mobile Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket - Intellectia AI

Feb 16, 2026
pulisher
Feb 16, 2026

Aptevo Therapeutics Inc. (NASDAQ:APVO) Sees Significant Drop in Short Interest - Defense World

Feb 16, 2026
pulisher
Feb 15, 2026

Will Aptevo Therapeutics Inc. stock remain a Wall Street favorite2025 Performance Recap & Long-Term Investment Growth Plans - mfd.ru

Feb 15, 2026
pulisher
Feb 14, 2026

Will Aptevo Therapeutics Inc. be affected by tariffsCPI Data & AI Based Buy and Sell Signals - mfd.ru

Feb 14, 2026
pulisher
Feb 13, 2026

Can Aptevo Therapeutics Inc. navigate macro headwindsJuly 2025 News Drivers & Technical Buy Zone Confirmation - mfd.ru

Feb 13, 2026
pulisher
Feb 12, 2026

What is Aptevo Therapeutics Inc.’s valuation compared to sectorM&A Rumor & Accurate Entry/Exit Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 12, 2026

Why Aptevo Therapeutics Inc. stock attracts high net worth investorsProduct Launch & Real-Time Market Sentiment Alerts - mfd.ru

Feb 12, 2026
pulisher
Feb 11, 2026

Is Aptevo Therapeutics Inc. stock a value trapQuarterly Portfolio Review & Scalable Portfolio Growth Ideas - mfd.ru

Feb 11, 2026
pulisher
Feb 10, 2026

Aug Rallies: What is Aptevo Therapeutics Inc. s 5 year growth outlookJuly 2025 Setups & Verified Entry Point Detection - mfd.ru

Feb 10, 2026
pulisher
Feb 05, 2026

Risk Report: Is Aptevo Therapeutics Inc impacted by rising ratesChart Signals & Safe Swing Trade Setups - baoquankhu1.vn

Feb 05, 2026
pulisher
Feb 04, 2026

Is Aptevo Therapeutics Inc. stock a top momentum playSell Signal & Reliable Entry Point Alerts - mfd.ru

Feb 04, 2026
pulisher
Feb 04, 2026

Aptevo Therapeutics Announces CEO Transition and Leadership Changes - The Globe and Mail

Feb 04, 2026
pulisher
Feb 03, 2026

Aptevo Therapeutics announces leadership changes as CEO retires By Investing.com - Investing.com Canada

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo Announces CEO Changes - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo Therapeutics Inc. Announces Board and Executive Changes - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo Therapeutics Names Jeff Lamothe President and CEO as Marvin White Becomes Executive Chair - citybiz

Feb 03, 2026
pulisher
Feb 03, 2026

Is Onto Innovation Inc stock risky to hold now2025 Support & Resistance & Detailed Earnings Play Strategies - baoquankhu1.vn

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo Therapeutics (APVO) Announces Changes in Leadership to Pr - GuruFocus

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo Therapeutics IncMarvin White to retire as Aptevo CEO effective April 1, 2026SEC filing - marketscreener.com

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo Announces Executive Leadership Transitions to Support Next Phase of Growth - The Globe and Mail

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo Therapeutics announces leadership changes as CEO retires - Investing.com

Feb 03, 2026
pulisher
Feb 03, 2026

Aptevo (NASDAQ: APVO) elevates COO Jeff Lamothe to succeed CEO Marvin White - Stock Titan

Feb 03, 2026
pulisher
Feb 03, 2026

Cancer drug developer Aptevo hands CEO role to operations chief - Stock Titan

Feb 03, 2026
pulisher
Jan 28, 2026

Aptevo Therapeutics (APVO) Announces Offering of 7.075 Million S - GuruFocus

Jan 28, 2026
pulisher
Jan 28, 2026

Aptevo Therapeutics prospectus relates to offer and sale of up to 7,075,471 shares of our common stock by selling stockholder - marketscreener.com

Jan 28, 2026
pulisher
Jan 28, 2026

Aptevo Therapeutics Prospectus Relates To Offer And Sale Of Up To 7,075,471 Shares Of Our Common Stock By Selling Stockholder - TradingView

Jan 28, 2026
pulisher
Jan 27, 2026

Aug Rallies: Is Aptevo Therapeutics Inc impacted by rising ratesJuly 2025 EndofMonth & Verified Chart Pattern Trade Signals - baoquankhu1.vn

Jan 27, 2026
pulisher
Jan 26, 2026

Growth Report: Can Compass Minerals International Inc. deliver consistent EPS growthInsider Selling & Community Verified Swing Trade Signals - baoquankhu1.vn

Jan 26, 2026
pulisher
Jan 21, 2026

12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga

Jan 21, 2026
pulisher
Jan 18, 2026

Take Profit: Is Weave Communications Inc a defensive stock2025 Analyst Calls & Accurate Intraday Trading Signals - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 18, 2026

VIX Spike: What are Aptevo Therapeutics Incs recent SEC filings showingTrade Exit Report & Fast Moving Market Watchlists - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 18, 2026

Chipmakers Recap: Is NTNX stock overvalued or fairly priced2025 Buyback Activity & Reliable Price Action Trade Plans - baoquankhu1.vn

Jan 18, 2026
pulisher
Jan 16, 2026

Aptevo Therapeutics (NASDAQ: APVO) seeks OK for $60M SEPA share sales - Stock Titan

Jan 16, 2026
pulisher
Jan 15, 2026

Income Plays: Does Eastman Kodak Company align with a passive investing strategy - baoquankhu1.vn

Jan 15, 2026
pulisher
Jan 14, 2026

Market Overview: How sensitive is HUHUTECH International Group Inc to inflationJuly 2025 Movers & Verified Momentum Stock Watchlist - baoquankhu1.vn

Jan 14, 2026
pulisher
Jan 14, 2026

Aptevo Therapeutics (APVO) Price Target Increased by 1,700.00% to 7,711.20 - Nasdaq

Jan 14, 2026
pulisher
Jan 11, 2026

Aptevo Therapeutics shares jump after $60 million equity facility secured - MSN

Jan 11, 2026
pulisher
Jan 10, 2026

HOKA Size Guide: What valuation multiples suggest for Aptevo Therapeutics Inc. stockNew Releases Roundup & road comfort picks for daily use - Улправда

Jan 10, 2026
pulisher
Jan 10, 2026

Aptevo Therapeutics Secures $60 Million Equity Financing Facility - The Globe and Mail

Jan 10, 2026
pulisher
Jan 09, 2026

Aptevo Therapeutics Inc. (APVO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Jan 09, 2026
pulisher
Jan 09, 2026

Aptevo Therapeutics stock jumps after securing $60 million equity line By Investing.com - Investing.com South Africa

Jan 09, 2026
pulisher
Jan 09, 2026

Aptevo Therapeutics stock jumps after securing $60 million equity line - Investing.com

Jan 09, 2026
pulisher
Jan 09, 2026

Aptevo Therapeutics Secures $60 Million Equity Line of Credit to Support Multispecific Portfolio Advancement, Increase Strategic Optionality - The Globe and Mail

Jan 09, 2026
$45.68
price down icon 3.69%
$53.83
price down icon 6.87%
$29.72
price up icon 0.68%
$101.95
price down icon 1.78%
$143.57
price down icon 4.21%
biotechnology ONC
$292.94
price down icon 2.03%
자본화:     |  볼륨(24시간):